Opinion Pieces Discuss COVID-19 Pandemic, Response, Including Regional Vaccine Manufacturing In Africa; Vaccine Rollout, Regulation; Funding For Global Efforts In Next U.S. Stimulus

Devex: Opinion: A call to boost African manufacturing for COVID-19 and other vaccines
Perrer Tosso, senior manager of advanced manufacturing technologies at USP, and Skhumbuzo Ngozwana, CEO of Kiara Health, chair of the board of Biovac, and board member of the Federation of African Pharmaceutical Manufacturers Association (12/16).

Financial Times: Should we take a chance and divert early booster shots to the unprotected?
Anjana Ahuja, science commentator at the Financial Times (12/15).

Financial Times: Beware the criminal threat to the fight against Covid
Vanda Felbab-Brown, senior fellow at Brookings Institution (12/16).

The Hill: Global Funding must be in the next COVID-19 emergency supplemental
Thomas J. Coates, director of the University of California Global Health Institute, distinguished research professor of Medicine at the UCLA David Geffen School of Medicine, and director emeritus of the UCLA Center for World Health (12/15).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.